Reneuron Group Plc (RENE.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2023 | 03-2022 | 03-2021 | 03-2020 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,153 | 9,548 | 14,703 | 12,625 | 20,432 |
| Marketable Securities | 1,000 | 5,000 | 7,500 | N/A | 5,954 |
| Other current assets | 1,685 | 1,928 | 2,276 | 6,522 | 3,643 |
| TOTAL | $8,838 | $16,476 | $24,479 | $19,147 | $30,029 |
| Non-Current Assets | |||||
| PPE Net | 621 | 661 | 686 | 1,043 | 632 |
| Intangibles | 186 | 186 | 186 | 186 | 186 |
| TOTAL | $807 | $847 | $872 | $1,229 | $818 |
| Total Assets | $9,645 | $17,323 | $25,351 | $20,376 | $30,847 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 319 | 734 | 1,722 | 2,426 | 2,546 |
| TOTAL | $4,320 | $7,019 | $5,884 | $6,446 | $7,430 |
| Non-Current Liabilities | |||||
| TOTAL | $268 | $416 | $562 | $707 | $0 |
| Total Liabilities | $4,588 | $7,435 | $6,446 | $7,153 | $7,430 |
| Shareholders' Equity | |||||
| Common Shares | 572 | 571 | 569 | 318 | 316 |
| Retained earnings | -151,957 | -147,125 | -138,085 | -127,502 | -117,120 |
| Other shareholders' equity | 2,223 | 2,223 | 2,223 | 2,223 | 2,223 |
| TOTAL | $5,057 | $9,888 | $18,905 | $13,223 | $23,417 |
| Total Liabilities And Equity | $9,645 | $17,323 | $25,351 | $20,376 | $30,847 |